Trial Profile
A comparison of the efficacy of levobupivacaine 0.125%, ropivacaine 0.125% and ropivacaine 0.2%, all combined with sufentanil 0.5 micrograms/mL, in patient-controlled epidural analgesia after hysterectomy under combined epidural and general anesthesia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary) ; Sufentanil
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 11 Jul 2011 New trial record